Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • JULY 2021 Issue has been successfully launched on 1 July 2021.



Babitha Kosuri*, Kare Shushrutha Nadh, Shaik Vaseem Najahat Fathima, Naveen Yaradesi and Padmalatha Kantamneni


Glucocorticoids are steroid hormones, which are therapeutically used in almost all medical specialities, as anti-inflammatory and immunosuppressant. Glucocorticoids are widely indicated to treat inflammatory disorders and autoimmune diseases like rheumatoid arthritis, multiple sclerosis, asthma, skin rashes, chronic obstructive pulmonary disease, acute gout and systemic lupus erythematosus. Although the successful evidence for the efficacy of glucocorticoids in the treatment, their clinical use is restricted by some side effects. However, a numerous side effects have been pointed associated with use of glucocorticoids including increased blood pressure and blood sugar levels, glaucoma, fluid retention, menstrual irregularities, weight gain, insomnia, stomach pain and infection. Approximately 40% and 70% of patients had been developed with new-onset of steroid induced hyperglycemia at 550-bed and 1000-bed teaching hospital respectively. The underlying and fundamental mechanisms of these effects of glucocorticoids are recognizable, complex and partly defined. Glucocorticoid induced hyperglycemia (GIH) is a transient condition, developed either by stimulating gluconeogenesis in hepatic metabolism or by showing inimical on insulin action. Early detection and appropriate management of glucocorticoid induced hyperglycemia should provide better remission for the patients receiving glucocorticoid treatment. This review article mainly focuses to highlight the prevalence, risk factors, pathogenesis and treatment guideline of glucocorticoid induced hyperglycemia.

Keywords: Glucocorticoids, Side effects, Hyperglycemia, Treatment.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More